今开:0.0 | 昨收:0.0207 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:603150.0 |
PLx Pharma(PLXP)2021-01-23 06:30
$PLx Pharma(PLXP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001019056-21-000054 Act: 34 Size: 115 KB 网页链接查看全文
PLx Pharma(PLXP)2021-01-07 19:06
$PLx Pharma(PLXP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000052 Act: 33 Size: 1 KB 网页链接查看全文
PLx Pharma(PLXP)2021-01-08 19:12
$PLx Pharma(PLXP)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001193805-21-000020 Act: 33 Size: 142 KB 网页链接查看全文
PLx Pharma(PLXP)2021-01-12 06:12
$PLx Pharma(PLXP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000921895-21-000070 Act: 34 Size: 132 KB 网页链接查看全文
PLx Pharma(PLXP)2019-11-09 06:30
$PLx Pharma(PLXP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-08 AccNo: 0001437749-19-022041 Size: 3 MB 网页链接查看全文
PLx Pharma(PLXP)2020-12-22 06:21
$PLx Pharma(PLXP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193805-20-001584 Act: 33 Size: 242 KB 网页链接查看全文
PLx Pharma(PLXP)2020-12-18 19:12
$PLx Pharma(PLXP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001019056-20-000644 Act: 34 Size: 115 KB 网页链接查看全文
PLx Pharma(PLXP)2019-11-09 06:30
$PLx Pharma(PLXP)$ 8-K - Current report Filed: 2019-11-08 AccNo: 0001193805-19-001403 Size: 93 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文
7X24快讯2021-07-20 21:35
制药公司PLX Pharma Inc.(PLXP.O)涨8.7%,公司的新型阿司匹林制剂Vazalore将于8月份在全国8000多家沃尔格林门店推出。查看全文
Guoran2018-03-28 08:11
$PLx Pharma Inc.(PLXP)$ 公司手上有一个FDA批准的阿斯匹林胶囊商业化,打算再申报一个小剂量的。另外想利用同种技术开发布洛芬。查看全文
查看最新行情 下载新浪财经APP,查看更多期货资讯和微博汇观点 原标题:美股盘前:IBM盘前涨4%,制药公司PLXP盘前涨超11% 来源:捕捉翻倍美股 IBM(IBM.N)盘前涨4%,第二季度营收较去年同期增长近3.5%,为2018... 网页链接
$PLx Pharma(PLXP)$ 8-K Current report, items 1.03 and 9.01 Accession Number: 0001193805-23-000557 Act: 34 Size: 208 KB 网页链接
$PLx Pharma(PLXP)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193805-23-000544 Act: 34 Size: 642 KB 网页链接
$PLx Pharma(PLXP)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001193805-23-000530 Act: 34 Size: 203 KB 网页链接
$PLx Pharma(PLXP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-011138 Act: 34 Size: 126 KB 网页链接
$PLx Pharma(PLXP)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001193805-23-000293 Act: 34 Size: 203 KB 网页链接
$PLx Pharma(PLXP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-038538 Act: 34 Size: 78 KB 网页链接
$PLx Pharma(PLXP)$ 8-K Current report, items 3.01, 5.02, and 9.01 Accession Number: 0001193805-23-000207 Act: 34 Size: 417 KB 网页链接
$PLx Pharma(PLXP)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001193805-23-000070 Act: 34 Size: 202 KB 网页链接
$PLx Pharma(PLXP)$ 8-K Current report, items 2.02, 5.02, 5.07, and 9.01 Accession Number: 0001193805-22-001510 Act: 34 Size: 320 KB 网页链接
$PLx Pharma(PLXP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-22-026958 Act: 34 Size: 4 MB 网页链接